SNAP-8 (10mg)
Spécifications techniques
| Pureté (HPLC) | ≥95% (HPLC) |
| Numéro CAS | 868844-74-0 |
| Forme | White lyophilized powder |
| Stockage | -20°C |
| Séquence | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ |
| Poids moléculaire | 1,075.17 g/mol |
| Forme saline | Acetate |
| Solubilité | Soluble in water |
SNAP-8 (10mg)
Prix catalogue EUR · HU, SK, CZ, PL
- Eurozone (EUR)81,00 EUR
- Hongrie (HU)81,00 EUR≈ 32 400 Ft
- Slovaquie (SK)81,00 EUR
- Tchéquie (CZ)81,00 EUR≈ 2 025 Kč
- Pologne (PL)81,00 EUR≈ 344,25 zł
Même prix catalogue en EUR pour livraison vers la Hongrie, la Slovaquie, la République tchèque et la Pologne. Paiement en EUR.
Montants HUF/CZK/PLN indicatifs convertis depuis l’EUR ; la Slovaquie utilise l’EUR. Taux approximatifs. Paiement en EUR.
Acetyl octapeptide-3 — SNAP-25 fragment for cosmetic muscle-contraction research. 10mg vial.
Strictement réservé à la recherche en laboratoire.
Non destiné à la consommation humaine, vétérinaire ou au diagnostic.
From the Peptide Explorer
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Key Mechanisms
- ›SNARE complex disruption
- ›SNAP-25 competitive inhibition
- ›Reduced neurotransmitter vesicle fusion
- ›Topical muscle relaxation
- ›Expression line reduction
Primary Research Areas
- ›Expression wrinkle research
- ›Topical neuromodulation
- ›SNARE complex pharmacology
Key Research Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Overview
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Origin: Extended analog of SNAP-25 competitor Argireline (Acetyl Hexapeptide-3)
Mechanism of Action
- SNARE complex disruption
- SNAP-25 competitive inhibition
- Reduced neurotransmitter vesicle fusion
- Topical muscle relaxation
- Expression line reduction
Primary Research Areas
- Expression wrinkle research
- Topical neuromodulation
- SNARE complex pharmacology
Key Published Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Protocol
Commonly studied routes: Topical. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
Room temperature in formulation
Important Notice
SNAP-8 (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Spécifications de recherche
Synthesized for strict analytical consistency. Verified via HPLC/MS.Voir les standards qualité →
Manipulation et stockage
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water